Here we examined the hypothesis that some stable HIV-infected partnerships can be found in cohort studies, as the patients frequently attend the clinic visits together.
Introduction
Identifying and characterizing steady -as opposed to occasional -HIV transmission pairs is a key challenge in HIV epidemiology and prevention, especially in light of data that suggest that steady partners are an increasing source of HIV infection with increasing age among men who have sex with men (MSM) [1, 2] .
In this work, we proposed and validated a new approach for identifying steady HIV transmission pairs and steady serosorting couples, that is, HIV-positive individuals who are not infected by the same viral variant but prefer other HIV-positive individuals as sexual partners. We examine the simple hypothesis that some steady partners can be identified in longitudinal cohorts, because they attend the follow-up and the laboratory visits together. This is likely to be reflected in the number of shared follow-up visits, with a frequency that is unlikely to be attributed to chance.
Identifying and characterizing HIV-positive steady transmission pairs has the potential to shed light on their demographic and epidemiological features, which are not likely to change after they become seroconcordant. Knowing these characteristics can facilitate targeted prevention of HIV transmission. Moreover, identification of steady HIV-positive pairs that engage in unprotected sex, given a still high prevalence of late treatment initiation and treatment interruptions [3, 4] , can widen the horizons of research on within-pair quasi-species exchange, transmitted drug resistance and viral recombination [5] . In addition to transmission pairs, the proposed method can identify steady serosorting couples. Detailed longitudinal data on these pairs are very scarce.
We used the Swiss HIV Cohort Study (SHCS) as a showcase for the applicability of our method as the SHCS is renowned for its breadth and depth of demographic and molecular data as well as for its high coverage of the HIV-positive population in Switzerland [6] . However, with 39 cohorts of HIV-infected individuals from Europe alone [7] , and large ongoing US cohorts [8] , this method is expected to have ample application opportunities.
Implementing the proposed concept allowed us to identify an epidemiologically relevant subpopulation of steady HIV-positive transmission pairs and serosorting couples of mixed ethnicity with large age gaps. Importantly, at the meta-level, our study demonstrates how a detailed, prospective, and de-identified data set can be used -if publicly available and in the wrong hands -to obtain sensitive information at the level of individual patients.
Methods
Study population: the Swiss HIV Cohort Study and the drug resistance database (SHCS-DRDB)
The SHCS is a large, prospective, multicentred, interdisciplinary study established in 1988. It is highly representative of the HIV epidemic in Switzerland, with an estimated coverage of at least 45% of all HIV-infected individuals, 69% of all AIDS patients in Switzerland and 72% of all individuals treated with antiretroviral therapy (ART) [6, 9] .
During the bi-annual follow-up visits, clinical and demographical data are collected for each participant using the study questionnaire, which includes a question about being in a steady partnership with another HIV-positive individual (without asking about the identity of the partner). In addition, the standard of care requires monitoring of viral load (since 1996) and CD4 count, every 3 months. In practice, every second visit is a combined cohort follow-up and laboratory monitoring visit; thus, on average, a patient is expected to have a total of at least four visits per year. Ideally, the visit dates are chosen by the patients without restrictions. The drug resistance database contains HIV-1 polymerase (pol) sequences for~60% of all patients ever included in the cohort and~85% of patients enrolled after 1996 [10] . The cohort database is de-identified.
Identification of steady transmission pairs and serosorting couples using shared follow-up visits Our method is based on the simple intuition that pairs of patients who share a larger number of visits than expected by chance are more likely to represent pairs who coordinate their visits to the clinics, which might reflect being either steady transmission pairs or serosorting couples. In its simplest version, this algorithm would use the number of shared visit dates within a couple as the test statistic. The threshold number of shared visits that can be expected by chance is determined by randomly shuffling cohort visits across individuals and counting the number of random visit collisions (a further explanation is given below). Pairs exceeding that threshold are flagged as candidate pairs for further evaluation and validation.
Below, we present a slight addition to this algorithm which also adjusts for the length of follow-up.
Briefly, for each patient who consistently visited only one of the seven SHCS study centres, all the shared visits with the other eligible patients from the same centre were extracted. To remove a potential bias stemming from a nonrandom choice of visit dates as a consequence of a wish to consistently visit a certain physician, we counted for each physician the median interval between the dates he/she sees patients. Visits of physicians who saw patients infrequently were excluded if a median time interval between the dates on which they saw SHCS patients exceeded 7 days. As these physicians have a large time span between visits, several patients might choose the days these physicians work and share large numbers of visits without actually being a pair.
Adjustment for the total number of visits per pair by a penalty term
The chances of two unrelated cohort members sharing a visit increase with the overall number of visits of each member of the pair. To account for this, we adjusted the number of shared visits per pair using the following intuition: visits occur typically each quarter and a quarter has approximately 75 eligible days for visits. If we make the simplifying assumption that all visits for an individual with the lower number of visits within a pair fall within quarters where the other individual also has a visit and that the visits are distributed uniformly and independently across the 75 eligible dates of each quarter (this parameter should be tailored to each cohort; see Supporting Information S1 for sensitivity analysis with a 30-day window), then the probability of obtaining S shared visit dates per randomly chosen pair can be approximated as:
where T a and T b are the total number of visits made by patients a and b, respectively, and S is the number of shared visits. p shared can now be used to identify pairs of patients whose number of shared visits is very unlikely to occur by chance (by determining a threshold and considering all pairs with p shared below this threshold as potential transmission or serosorting pairs; see the Bonferroni-corrected method below) and takes into account the effect of unequal visit numbers on the probability of sharing visits. As our main concern is false positives (artificially low p shared ) and the last factor is expected to be large, we assume that:
Finally, we consider instead ofp shared the equivalent quantity S 0 (Eqn. 3). Equivalence here means that selecting potential stable transmission and serosorting pairs as those whosep shared is lower than a thresholdp thr yields the same pairs as selecting those pairs whose S 0 is above a threshold S 0 thr , where S 0 thr ¼ Àlogðp thr Þ= logð75Þ:
S 0 can be interpreted as an effective (adjusted) number of shared visits penalized by the term:
This accounts for the varying background probability of shared visits as reflected in the varying length of follow-up. Note that min(T a ,T b ) ensures a differential penalty such that if S = min(T a ,T b ) the penalty is zero and the larger the min(T a ,T b ) À S the larger the penalty, reflecting the intuition that if all the visits of one member of the pair are shared with the other [hence S = min(T a , T b )], then there is a higher probability that such a pair is related (and hence should not be penalized).
Determining the threshold for the number of shared visits using shuffling As a consequence of the multiple comparisons problem (3 029 261 pairs were analysed) and strongly simplifying assumptions about the uniform distribution of visits, the above expressions cannot be used to directly derive threshold values for the effective number of shared visits S 0 . Hence, we used the following shuffling strategy to derive the null distribution. For each of the seven study centres, the visits were shuffled within each quarter (such that the original distribution of the number of visits per individual was preserved) and the number of randomly collided shared visits per pair was counted and penalized using Eqn. 3. In other words, the observed visit dates from a given quarter were randomly reassigned between the patients who attended during this quarter (see Supporting Information S1 for shuffling within a 30-day window). The shuffling procedure was replicated 100 times and allowed us to estimate the background number of shared visits that are expected to occur by chance for each centre (Fig. 1 ). From these shuffled data sets, we estimated the fraction of pairs that were expected to be falsely identified in our data set as transmission/serosorting pairs for a given threshold S Alternative method: determining the threshold for the number of shared visits using Bonferroni correction An alternative and less computationally demanding approach for the detection of possible steady pairs would be calculating the probability of sharing a given number of visits (p shared ) using Equation 1, and then determining the selection cut-off using Bonferroni correction [11] for multiple comparisons [Type I error alpha (0.01)]/[number of pairs that shared at least one visit (3 029 261)]. Pairs with p shared below the threshold were flagged for further evaluation. We implemented both approaches (shuffling and Bonferroni correction) and compared their performances.
Phylogenetic tree and genetic distances
We used phylogenetic linkage as a key criterion for the validation of the putative steady transmission pairs that were detected using this method. A total of 19 893 partial HIV-1 pol sequences from 10 970 SHCS cohort participants (years 1989-2015) were pooled with 116 408 background, non-Swiss HIV-1 pol sequences from the Los Alamos database for a large phylogenetic tree constructed using FASTTREE [12] . See Supporting Information S1 for technical details.
Ethics
Ethical approval of the SHCS and written informed consent from all participants were obtained.
Statistical analysis
Statistical analysis was performed using R (v 3.2.3) [13, 14] with some functions written in C++ to improve performance [15] .
R package
An R package named svisits was constructed to facilitate easy application (available at https://github.com/alex marzel/svisits). A short vignette that demonstrates the package application can be found in Supporting Information S2. A data set with visit dates that were simulated (to protect our patients' privacy; see Discussion) using the empirical distributions in the SHCS is embedded in the package.
Results

Data description
We analysed data for 16 139 SHCS patients, accounting for a total of 434 432 visits from 1990 to 2014. A total of 3 029 261 pairs of patients who attended the same clinic on the same day at least once were identified across all seven centres. For those pairs, the number of unadjusted shared visits per pair ranged between 1 and 72, with a median of 1 (IQR: 1-2). This indicates that sharing more than one visit with another patient was rare. Following the shuffling and the correction penalty, the 1% false-positive thresholds for each centre ranged from 5 to 6 effective shared visits per pair (Fig. 1) , depending on the centre.
Method validation
In line with our assumption, the number of eligible days for a visit did not change substantially during the followup time, with a median of 62 (IQR: 55-65) days per quarter. In 192 out of 3 029 261 pairs, the number of adjusted shared visits exceeded the established thresholds S 0 thr ; these pairs were selected for further evaluation. Two pairs comprised of heterosexual women were excluded as implausible transmission pairs. The remaining pairs were validated as potential transmission pairs using three criteria: (i) monophyletic clustering on the extensive (136 301 tips) phylogenetic tree and a maximal genetic distance of 2.5% between sequences; (ii) a self-report of having an HIV-positive steady partner by both members of the pair during the period between the first and the last shared visits with the other member (question introduced in the SHCS questionnaire in the year 2000); (iii) belonging to the same HIV transmission risk group (MSM, heterosexual or injecting drug use).
Of the identified pairs, 89 had available data for all three validation criteria. Of these, 50 clustered on the phylogeny and were below the genetic distance cut-off. Thirty-three pairs (33 of 89; 37%) were confirmed using all three criteria (Fig. 2) . The median pairwise genetic distance of the viruses from these 33 pairs was low, 0.5% (IQR: 0.15-0.98%), supporting the conclusion that these were HIV transmission pairs [16, 17] . Additionally, the ShimodairaÀHasegawa local node support values for the most recent common ancestor (MRCA) node between the two pair members were also high, with a median of 97% (IQR: 92-99%), suggesting a high phylogenetic certainty of the monophyletic clusters.
Eight pairs were not linked by the phylogeny but were risk group concordant and declared having an HIV-positive steady partner. These pairs, who did not share a genetically similar clone of the virus (median genetic distance 8.5%; IQR: 3.5-10%) but had many shared visits (median 13; IQR: 8-23; adjusted), might represent not transmission but steady serosorting couples (Fig. 2) ; however, these pairs require stricter validation (Supporting Information S1). Fourteen of 89 (15.7%) pairs were discrepant by all three criteria and can be attributed to a residual nonrandom clustering of visit dates which was not efficiently accounted for by shuffling as a consequence of latent nonrandom visiting patterns.
Importantly, the 33 pairs validated by all three criteria had a significantly higher median number of effective shared visits in comparison to pairs that were not validated by any of the criteria; 16 versus 6, respectively (Wilcoxon P < 0.0001; P for trend = 0.044), which supports our basic concept that a high number of effective shared visits is indicative of a putative transmission pair (Fig. 3, top) . Moreover, we also noticed that the pairs that were validated by all criteria had a significantly lower median number of total visits per pair (T a + T b ) than unvalidated pairs (64 versus 153, respectively; Wilcoxon P < 0.0001; P for trend = 0.047; Fig. 3, bottom) . This indicates that the latter pairs were probably false positive because of the overall very high number of visits per pair, despite the adjustment for the total follow-up time per pair (which is effective but not perfect).
Finally, we explored whether there was a negative association between the effective (penalized) and unadjusted number of shared visits and the minimal genetic distance within each pair, among the 89 pairs eligible for validation. For the adjusted visits, the Spearman's rho was À0.35 (P < 0.0001), while the association for unadjusted visits was weaker and nonsignificant, À0.17 (P = 0.11), further supporting both our basic assumption concerning the correlation between the number of shared visits and being a possible transmission pair (i.e. more shared visits, the closer are the viruses) and the necessity of penalizing the total follow-up time per pair.
As an alternative, faster set-up, applying the Bonferroni-corrected threshold provided qualitatively equivalent results with a total yield of 271 candidate pairs (Fig. 4) . The overlap between the two approaches was high: 192 pairs. Validation analysis revealed the same 33 transmission pairs (validated by all three criteria) as found using the shuffling, plus three additional pairs -adding face validity to our study -as well as the same eight serosorting pairs plus one. However, this approach had a slightly higher false-positive rate; of the 132 of 271 pairs that had available data for validation, 23% (31 of 132) were not validated by any of the three criteria as compared with 16% false positives using the shuffling (not significant; P = 0.16) Chi-squared test.
Characterization of steady transmission pairs
Following the detection and the validation of the 33 potential steady transmission pairs, we went on to characterize their main features. Twenty-six pairs (79%; 26 of 33) were heterosexual and seven pairs were MSM.
In 15 pairs both members were of white ethnicity, five pairs were concordantly of black ethnicity and one pair was concordantly Asian. Twelve pairs (36%; 12 of 33) were of mixed ethnicity; ten were whiteÀAsian (eight were heterosexual, with the man always being white, and two were MSM pairs). The two remaining inter-ethnic pairs consisted of a white man and a Latino woman. Pairwise comparisons showed that whiteÀAsian pairs had a significantly higher mean age gap in comparison to whiteÀwhite and blackÀblack pairs [19 years versus 6.7 years (P = 0.002) and 5.6 years (P = 0.025), respectively; Tukey and Kramer (Nemenyi) test [18] ; Fig. 5 ].
Among the ten whiteÀAsian couples, eight had virus of subtype CRF01_AE, one virus of subtype 02_AG, and one virus of subtype B, while among the whiteÀwhite pairs, the majority (73%; 11 of 15) had virus of subtype B (Fisher's exact test; P = 0.002).
Next, we examined whether these steady pairs used condoms during the period between the first and last shared visits. We found that 27 of 33 (82%) reported condomless sex with a steady partner during the assumed steady partnership period. Notably, seven births were recorded by seven different women. In six of these seven cases, the man declared that he had fathered a child during the corresponding periods, which further adds to the validity of our definition of the pairs as steady, as it is well documented in sociological research that childbearing decreases the probability of union dissolution [19] .
Discussion
We have presented an epidemiological data mining approach to identify putative transmission pairs or serosorting couples based on shared visit dates in observational cohorts. There has been a growing use of HIV Fig. 3 Relationship between the number of validation criteria that were met by the putative steady partnerships (x-axis) and the effective number of shared visits per pair (y-axis, top), as well as the joint number of visits made by both pair members (y-axis, bottom).
resistance test sequences for epidemiological linkage of transmission pairs, which has led to important insights into key questions in HIV epidemiology [3, 17, [20] [21] [22] . However, it is also clear that phylogenetic linkage alone cannot prove transmission [23] [24] [25] . This is mainly because the validity of the phylogenetic clustering is highly dependent on the sampling density of the target population [24] . Our approach has the advantage of detecting putative transmission pairs first based on an aberrant number of shared visits, then validating them using phylogeny or other available criteria, hence without putting the entire weight of evidence on the phylogeny.
As is often the case in data mining, the main usefulness of our method lies not in its predictive accuracy, but in its ability to narrow the screened population from millions of possible combinations to several dozen candidate pairs that are to be assessed in depth and validated, as screening and validation of all the possible combinations are otherwise impractical. Hence, the method is mainly useful as an a priori filtering tool with a good inputto-output ratio. By the same token, classical epidemiological concepts such as positive predictive value and receiver operating characteristic (ROC) are not applicable to this problem, because the real structure of the transmission chains is mostly unknown [23] [24] [25] .
We refrain from arguing that pairs that share clinic visits are representative of all HIV-positive steady pairs. Yet, even if these pairs are selective, this does not nullify the biological level insights that can be gained by using their samples. As early treatment initiation is now universally recommended regardless of CD4 count [26] , a method for retrospective detection of transmission pairs that is based on samples that have already been collected and stored is timely.
We found eight heterosexual, mixed-ethnicity steady transmission pairs with subtype CRF01_AE. This result is in line with a recently published analysis of the global dispersal patterns of this subtype which is prevalent in Asia, predominantly in Thailand. Angelis et al. [27] showed that Switzerland experienced at least 15 heterosexually driven migration events of CRF01_AE, which is larger than expected and the highest number in continental Europe. Our study suggests that steady, mixed-ethnicity partnerships with a large age gap (with the man being white and older) contribute to these introduction events. This observation opens up a targeted prevention opportunity.
Apart from epidemiological level insights, identification of steady transmission and serosorting pairs can widen the horizons of research at the biological level, providing insights into problems that are otherwise difficult to tackle; for example: (i) prospective viral quasi-species exchange between the steady partnership members (both transmission pairs and serosorting couples), given the fact that treatment interruption is still prevalent [3] ; (ii) exchange of transmitter-founder strains and prospective viral diversification, and (iii) within-pair transmission of drug resistance. In addition to research questions centred around HIV biology and epidemiology, the detected pairs can shed light on within-pair transmission of other common sexually transmitted infections (e.g. syphilis) which are currently on the rise in the HIVpositive population [28, 29] .
Our study also demonstrates how even de-identified data, when aggregated longitudinally and in great detail, can still be used to obtain information about individuals and their health, sexual patterns and habits. In the era of 'big data' and its increased -and as some argue inevitable [30] -use in public health research, our study emphasizes that greater effort should be made to protect the privacy of the patients and that making anonymized health data publicly available might lead to unexpected consequences [31] . Similar privacy concerns, but in the context of the deposition of anonymized sequencing data sets, were raised by Gymrek et al. [32] who were able to successfully identify personal genomes by combining anonymized metadata with Y-chromosome haplotypes.
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